SBC
NASDAQ · Health Care
Sbc Medical Group Holdings I
$3.70
+0.07 (+1.93%)
Financial Highlights (FY 2026)
Revenue
222.38M
Net Income
50.46M
Gross Margin
76.0%
Profit Margin
22.7%
Rev Growth
—
D/E Ratio
0.03
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 76.0% | 48.2% | 48.2% | 48.2% |
| Operating Margin | 36.1% | 9.9% | 10.4% | 8.9% |
| Profit Margin | 22.7% | 9.2% | 8.0% | 9.2% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 222.38M | 196.08M | 204.47M | 208.63M |
| Gross Profit | 168.94M | 94.42M | 98.46M | 100.46M |
| Operating Income | 80.23M | 19.35M | 21.28M | 18.55M |
| Net Income | 50.46M | 18.01M | 16.26M | 19.19M |
| Gross Margin | 76.0% | 48.2% | 48.2% | 48.2% |
| Operating Margin | 36.1% | 9.9% | 10.4% | 8.9% |
| Profit Margin | 22.7% | 9.2% | 8.0% | 9.2% |
| Rev Growth | — | +18.0% | +6.4% | +0.5% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 7.20M | 196.46M | 197.20M | 186.85M |
| Total Equity | 211.80M | 161.40M | 138.37M | 145.87M |
| D/E Ratio | 0.03 | 1.22 | 1.43 | 1.28 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 83.65M | 25.90M | 26.85M | 24.03M |
| Free Cash Flow | — | 13.43M | 11.81M | 14.26M |